SARS-CoV-2 Spike-specific IFN-gamma T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

RECOVAC Consortium, Celine Imhof*, A. Lianne Messchendorp, Marieke van der Heiden, Carla C. Baan, Renate G. van der Molen, Ester B. M. Remmerswaal, Rory D. de Vries, Dimitri A. Diavatopoulos, Annemarie Boerma, Femke J. Bakker, Emily Oosterhout, Frederike J. Bemelman, Luuk B. Hilbrands, Marlies E. J. Reinders, Ron T. Gansevoort, Jan-Stephan Sanders, Debbie van Baarle

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Downloads (Pure)


Background. Studies have shown that coronavirus disease 2019 (COVID-19) vaccination is associated with a lower humoral response in vulnerable kidney patients. Here, we investigated the T-cell response following COVID-19 vaccination in kidney patients compared with controls. Methods. Patients with chronic kidney disease (CKD) stage G4/5 [estimated glomerular filtration rate

Original languageEnglish
Article number1387
Number of pages11
JournalTransplantation direct
Issue number11
Publication statusPublished - Nov-2022

Cite this